The ENRICH study examined BRII-179 as a priming therapy before administering elebsiran and PEG-IFNα.

SHANGHAI and GUANGZHOU, China, July 4, 2026 /PRNewswire/ -- Sanyou Biopharmaceutical Co., Ltd. ("Sanyou Bio") and Guangzhou Baiyunshan Xihe Health Pharmaceutical Co., Ltd. ("Baiyunshan Xihe") jointly ...

A multi-millionaire who made it his life’s mission to defeat death has been diagnosed with an incurable autoimmune disease.

Novartis will pay $1.1bn upfront and up to $400m in milestones for Myricx Bio, a UK firm developing a novel payload for antibody-drug conjugates.

Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio (“Myricx”) has reached agreement to be acquired by Novartis, for up to ...

Swiss pharma heavyweight Novartis is cutting a very large check. The company has agreed to acquire London-headquartered ...

Cambridge-based cell programming company bit.bio has introduced two new media kits for its iPSC-derived ioGlutamatergic ...

------------------------------------------------------- Follow Brit+Co for all things food, style, and entertainment!

Bryan Johnson, who spends $2 million a year on his health, claims his gastritis is linked to his sugary childhood diet, as ...

The UK Government has prioritised life science sector growth, but industry members have called for more funding.

A biohacker who wants to 'live forever' has been diagnosed with an incurable disease, but this doesn't mean that he's going ...

Built on enzymatic technology, ZymeCO develops biological tools that break down turf thatch, algae and organic matter.